Alcoa kicks off earnings season, but it’s biotech Illumina that in the spotlight (and not for good reasons). Bill Barker and Bill Mann from Motley Fool Funds discuss those stories plus Samsung’s decision to kill the Galaxy Note 7, Warren Buffett’s response to Donald Trump, a couple of tangents and more.
